Peer reviewed
Efficacy and safety of retatrutide in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
Bajaj HS, Welch M, Shah P, et al. Efficacy and safety of retatrutide in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial. Lancet. 2026;407(10546):2402-2413. doi:10.1016/S0140-6736(26)00967-0. PMID 42250575.
National Library of MedicinePublished 2026Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- National Library of Medicine
- Source type
- Peer reviewed
- Registry ID
research-reta-06- DOI
- 10.1016/S0140-6736(26)00967-0
- PMID
- 42250575
- Source code
- RETA-06
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.